MOLLY FUREY: Open Payments
NPI 1295248052 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,215 in 119 payments from 15 companies in 2025. Trend: 2023 $643 · 2024 $2,824 · 2025 $2,215
Food & beverage: $2,215
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $388 |
| Lilly USA, LLC | 19 | $358 |
| ABBVIE INC. | 11 | $268 |
| PFIZER INC. | 18 | $260 |
| Novo Nordisk Inc | 15 | $231 |
| Amgen Inc. | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 6 | $127 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $86 |
Products named: NURTEC ODT, MOUNJARO, FARXIGA, UBRELVY, AIRSUPRA, REXULTI, Ozempic, JARDIANCE.
Industry payments across NC — which companies pay providers there.
